New rules! Same problems! III part

In my previous post, I talked about why the regulatory aspect is as important as the efficacy when we are developing a new product or ingredient.

Following this line, today, I would to talk about the principal problem of the EFSA Health Claims regulation, from a user point of view.

Continue reading New rules! Same problems! III part